Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

393 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Melanoma.
Schadendorf D, Fisher DE, Garbe C, Gershenwald JE, Grob JJ, Halpern A, Herlyn M, Marchetti MA, McArthur G, Ribas A, Roesch A, Hauschild A. Schadendorf D, et al. Among authors: gershenwald je. Nat Rev Dis Primers. 2015 Apr 23;1:15003. doi: 10.1038/nrdp.2015.3. Nat Rev Dis Primers. 2015. PMID: 27188223 Review.
Classification and staging of melanoma.
Gershenwald JE, Buzaid AC, Ross MI. Gershenwald JE, et al. Clin Lab Med. 2000 Dec;20(4):785-815. Clin Lab Med. 2000. PMID: 11221515 Review.
Imaging studies in patients with melanoma.
Choi EA, Gershenwald JE. Choi EA, et al. Among authors: gershenwald je. Surg Oncol Clin N Am. 2007 Apr;16(2):403-30. doi: 10.1016/j.soc.2007.03.004. Surg Oncol Clin N Am. 2007. PMID: 17560520 Review.
Phase II trial of imatinib mesylate in patients with metastatic melanoma.
Kim KB, Eton O, Davis DW, Frazier ML, McConkey DJ, Diwan AH, Papadopoulos NE, Bedikian AY, Camacho LH, Ross MI, Cormier JN, Gershenwald JE, Lee JE, Mansfield PF, Billings LA, Ng CS, Charnsangavej C, Bar-Eli M, Johnson MM, Murgo AJ, Prieto VG. Kim KB, et al. Among authors: gershenwald je. Br J Cancer. 2008 Sep 2;99(5):734-40. doi: 10.1038/sj.bjc.6604482. Epub 2008 Aug 19. Br J Cancer. 2008. PMID: 18728664 Free PMC article. Clinical Trial.
A novel AKT3 mutation in melanoma tumours and cell lines.
Davies MA, Stemke-Hale K, Tellez C, Calderone TL, Deng W, Prieto VG, Lazar AJ, Gershenwald JE, Mills GB. Davies MA, et al. Among authors: gershenwald je. Br J Cancer. 2008 Oct 21;99(8):1265-8. doi: 10.1038/sj.bjc.6604637. Epub 2008 Sep 23. Br J Cancer. 2008. PMID: 18813315 Free PMC article.
Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma.
Davies MA, Stemke-Hale K, Lin E, Tellez C, Deng W, Gopal YN, Woodman SE, Calderone TC, Ju Z, Lazar AJ, Prieto VG, Aldape K, Mills GB, Gershenwald JE. Davies MA, et al. Among authors: gershenwald je. Clin Cancer Res. 2009 Dec 15;15(24):7538-7546. doi: 10.1158/1078-0432.CCR-09-1985. Clin Cancer Res. 2009. PMID: 19996208 Free PMC article.
Clinical correlates of NRAS and BRAF mutations in primary human melanoma.
Ellerhorst JA, Greene VR, Ekmekcioglu S, Warneke CL, Johnson MM, Cooke CP, Wang LE, Prieto VG, Gershenwald JE, Wei Q, Grimm EA. Ellerhorst JA, et al. Among authors: gershenwald je. Clin Cancer Res. 2011 Jan 15;17(2):229-35. doi: 10.1158/1078-0432.CCR-10-2276. Epub 2010 Oct 25. Clin Cancer Res. 2011. PMID: 20975100 Free PMC article.
Targeted therapy for melanoma: a primer.
Davies MA, Gershenwald JE. Davies MA, et al. Among authors: gershenwald je. Surg Oncol Clin N Am. 2011 Jan;20(1):165-80. doi: 10.1016/j.soc.2010.09.003. Surg Oncol Clin N Am. 2011. PMID: 21111965 Free PMC article. Review.
393 results